eASC
Cx621-0101
Phase 1 gene_therapy completed
Quick answer
eASC for Localized Adverse Reaction to Administration of Drug is a Phase 1 program (gene_therapy) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Localized Adverse Reaction to Administration of Drug
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- completed